image
Annovis Bio, Inc. ANVS
Healthcare - Biotechnology - NYSE - US
Watchlist
$ 6.84
-1.87 %
$ 94.4 M
Market Cap
-1.72
P/E
INCOME STATEMENT
0 REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-45 M OPERATING INCOME
-76.53%
Growth Rates
1Year -76.53%
3Years -89.29%
5Years -129.08%
7Years 0.00%
10Years 0.00%
-56.2 M NET INCOME
-121.90%
Growth Rates
1Year -121.90%
3Years -117.51%
5Years -139.46%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Annovis Bio, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 45 M
Operating Income -45 M
Other Expenses 11.2 M
Net Income -56.2 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 0 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 45.0 25.5 14.5 5.5 0.9 0.7 0.7
Selling, General and Administrative Expenses 6.2 9.0 6.1 3.6 0.8 0.6 0.4
Research and Development Expenses 38.8 16.5 8.5 3.1 0.8 0.1 0.3
Operating Income (45.0) (25.5) (14.5) (6.6) (1.6) (0.7) (0.7)
PRE-TAX INCOME
Interest Income Expense 0 (0.2) 0 47.2 (40.9) 66 84
Total Other Income (11.2) 0.2 50.1 K 1.2 0.6 66 84
Pre-Tax Income (56.2) (25.3) (14.5) (5.5) (1.0) (0.7) (0.7)
NET INCOME
Tax Provision 0 (0.2) 50.1 K (1.2) (0.7) 132 (0.7)
Net Income (56.2) (25.1) (14.4) (4.3) (0.3) (0.7) (0.7)
EPS 6.23 3.08 1.89 0.67 0.066 0.16 0.16